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Abstract
This paper proposes a new class of nonparametric tests for the correct specifi-
cation of generalized propensity score models. The test procedure is based on two
different projection arguments, which lead to test statistics with several appealing
properties. They accommodate high-dimensional covariates; are asymptotically in-
variant to the estimation method used to estimate the nuisance parameters and do
not requite estimators to be root-n asymptotically linear; are fully data-driven and
do not require tuning parameters, can be written in closed-form, facilitating the
implementation of an easy-to-use multiplier bootstrap procedure. We show that
our proposed tests are able to detect a broad class of local alternatives converging
to the null at the parametric rate. Monte Carlo simulation studies indicate that
our double projected tests have much higher power than other tests available in the
literature, highlighting their practical appeal.
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1 Introduction
One of the primary goals of many scientific fields is to quantify the effect of an expo-
sure/policy/treatment on a particular outcome of interest. When assignment to treat-
ment is not randomized, groups with different levels of the treatment variable usually
differ in important ways other than the observed treatment. Because these differences
are many times associated with the outcome variable, ascertaining the causal effect of the
treatment requires more sophisticated statistical tools than simple comparison of means.
It is in this setting that the propensity score of Rosenbaum and Rubin (1983) and its
multi-valued generalizations introduced by Imbens (2000) have been shown to be among
the most widely used tools for causal inference.
The propensity score was initially introduce by Rosenbaum and Rubin (1983) to ad-
just for observable differences between the treatment and comparison groups when treat-
ment is binary; it is defined as the conditional probability of receiving treatment given a
vector of pre-treatment covariates. It is now well understood that one can use propensity
scores to estimate causal effects through matching, weighting, regression, subclassification
or their combinations; see Imbens and Rubin (2015) for a textbook treatment.
In many empirical applications, however, treatments are not binary but multi-valued.
In such cases, instead of using the binary propensity score as a tool to estimate causal
effects, one can use its multi-valued generalization introduced by Imbens (2000), the
generalized propensity score, which is defined as the conditional probability of receiving
a specific level of the treatment given a vector of pre-treatment covariates. Similarly
to the binary treatment case, the generalized propensity score can be used to estimate
multi-valued causal effects through matching, weighting, regression, subclassification or
their combinations; see Linden et al. (2016) and Lopez and Gutman (2017) for excellent
overviews.
Although these statistical procedures that build on the generalized propensity score
are popular, a main concern of these methods is that the generalized propensity score
is usually unknown, and therefore has to be estimated. Given the high dimensionality
of available pre-treatment covariates and limited sample size, researchers are usually
coerced to adopt a parametric model for the generalized propensity score to bypass the
“curse of dimensionality”. Such a common practice raises the important issue of model
misspecifications. Indeed, as illustrated by Linden et al. (2016), model misspecifications
can lead to misleading treatment effect estimates. Thus, in practice, it is recommended
to assess if your putative model for the generalized propensity score is correctly specified.
In this paper, we propose new goodness-of-fit tests for parametric generalized propen-
sity score models. The main distinguishing feature of our tests is that they combine
two different projections: the first one to reduce the dimensionality of the problem and
the second one to eliminate the effect from replacing the unknown parameters of the
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generalized propensity scores with their estimators.
More specifically, our specification tests build on the dimension-reduction projection
introduced by Escanciano (2006), allowing us to effectively handle situations with mod-
erate number of covariates. Our tests also builds on Neyman (1959), Bickel et al. (2006),
Escanciano and Goh (2014), and Sant’Anna and Song (2019) in the sense that we ex-
plicitly acknowledge we do not know the “true” correct specification of the generalize
propensity score by making use of an orthogonal projection onto the tangent space of
nuisance parameters.
By combining these simple but powerful projections, we show that our proposed
specification tests for the generalized propensity score (a) do not severely suffer from the
“curse of dimensionality” when the vector of pre-treatment covariates is high-dimensional;
(b) are fully data-driven and do not require tuning parameters such as bandwidths; (c) do
not require estimators to be n1/2-asymptotically linear, with n the sample size; and (d) are
able to detect a broad class of local alternatives converging to the null at the parametric
rate. In order to facilitate its practical implementation, we obtain closed-form expressions
for our test statistics, and show that critical values can be computed with the assistance
of an easy-to-use multiplier-type bootstrap. To the best of our knowledge, no other
(specification) test available in the literature enjoys all these attractive properties (e.g.,
Escanciano, 2006, Mora and Moro-Egido, 2008, Shaikh et al., 2009, Escanciano and Goh,
2014, Garc´ıa-Portugue´s et al., 2014, Zhu et al., 2017, Sant’Anna and Song, 2019, and
Kim et al., 2020). The results of Monte Carlo simulations indicate that these attractive
properties translate to tests with excellent finite sample properties, even the dimension
of covariates is relatively high. As so, they can be routinely used to assess the reliability
of causal inference tools that rely on the generalized propensity score.
The rest of this article is organized as follows. In Section 2 we present the testing
framework and introduce our proposed double-projection specification tests. The asymp-
totic properties of our tests are established in Section 3. In Section 4 we present a detailed
description of an easy-to-implement multiplier-bootstrap procedure to compute critical
values. We then examine the finite sample properties of our tests via Monte Carlo sim-
ulations in Section 5, and an empirical illustration in Section 6. Section 7 concludes.
Mathematical proofs and additional simulation results are gathered in an appendix at
the end of the article.
2 Generalized propensity scores
2.1 Setup
For a generic d1 × d2 matrix A, A⊤ denotes the transpose of A. Let J ∈ N be a given
finite positive integer. We consider the potential outcome model of Rubin (1974). Let
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(X⊤, T, Y )⊤ be a random vector in a (dx + 2)-dimensional Euclidean space, where X ∈
X ⊆ Rdx is an observable dx × 1 vector of pre-treatment covariates with dx ∈ N, T
∈ T ⊆{0, 1, . . . , J} is the treatment random variable, Y =∑Tt=0 1 (T = t) Y (t) ∈ Y ⊆ R
is the observed outcome, and Y (t) denotes the potential outcome when T is externally
set to t. For the sake of simplicity, we focus our attention on average causal effects of the
form
β(t, s) ≡ E [Y (t)− Y (s)] , (1)
the average causal effect of exposing units to treatment t rather than treatment s; however
we can also cover quantile treatment effects and/or treatment effects for some treated
subpopulation (Lee, 2018, Ao et al., 2019). Henceforth, we assume that a random sample{
(X⊤i , Ti, Yi)
⊤, i = 1, . . . n
}
is available.
Imbens (2000) shows that if assignment to treatment T is weakly unconfounded given
pre-treatment variables X , (1) is identified by the following weighting estimands:
E
[
Y 1 (T = t)
pt (X)
]
− E
[
Y 1 (T = s)
ps (X)
]
=
E
[
Y 1 (T = t)
pt (X)
]
E
[
1 (T = t)
pt (X)
] − E
[
Y 1 (T = s)
ps (X)
]
E
[
1 (T = s)
ps (X)
] = β(t, s) (2)
where, for each t ∈ T , pt (x) ≡ P (T = t|X = x) = E [1 (T = t) |X = x] is the true,
unknown generalized propensity score, which is assumed to be uniformly bounded away
from zero for all t ∈ T . Importantly, (2) covers the binary, multinomial unordered and
multinomial ordered treatment settings in a unified setting.
The identification result in (2) suggests a two-step estimation procedure. In the
first step, one estimates the generalized propensity scores {pt (x) , t ∈ T }. Typically, re-
searchers assume a parametric model {qt (x, θt) , t ∈ T } for {pt (x) , t ∈ T }, where, for
each t ∈ T , qt(x, θt) : X × Θ 7→ [0, 1] denotes a family of parametric functions known
up to the finite dimensional parameter θt. By construction,
∑J
j=0 qj(x, θj) = 1. The
putative models qt(x, θt) depend on the underlying nature of the treatment. When treat-
ment is binary, a common specification for q1(X, θ1) is the logistic model q1(X, θ1) =
exp (X ′θ1) / (1 + exp (X
′θ1)) (e.g., Rosenbaum and Rubin, 1983, 1984). When treat-
ments are multi-valued, qualitatively distinct and without a logical ordering, a popular
specification for {qt (x, θt) , t ∈ T } is the multinomial logit model (e.g., Imbens, 2000),
qt (X, θt) =
exp (X ′θt)
1 +
∑J
j=1 exp (X
′θj)
, t ∈ {1, . . . , J} .
Finally, when treatments are multi-valued and correspond to ordered levels of treatment
such as dosages, a popular model for the treatment allocation T is the ordered logistic
model (e.g., McCullagh, 1980, Joffe and Rosenbaum, 1999, Lu et al., 2001, and Uysal,
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2015),
ln
( ∑t
j=0 qj (X, θj)
1−∑tj=0 qj (X, θj)
)
= αt −X ′γ, t ∈ {0, 1, . . . , J − 1} .
Researchers then estimate the unknown parameters θ = {θt, t ∈ T } by maximizing the
empirical fit of the generalized propensity score model. This is usually done by maximiz-
ing the log-likelihood function:
θ̂mlen ≡
{
θ̂mlen,t , t ∈ T
}
= argmin
θ∈Θ
n∑
i=1
(
J∑
s=0
1 {Ti = s} log (qs (Xi, θs))
)
, (3)
though we emphasize that alternative estimation procedures can also be used.
Armed with a (generic) estimator θ̂n ≡
{
θ̂n,t, t ∈ T
}
, we can proceed to the second
step by computing the estimated values for the generalized propensity score, and then
use the analogy principle to estimate the average causal effects β(t, s) :
β̂n(t, s; θ̂n) =
n∑
i=1
 wt
(
Ti, Xi; θ̂n
)
∑n
j=1wt
(
Tj , Xj; θ̂n
) − ws
(
Ti, Xi; θ̂n
)
∑n
j=1ws
(
Tj , Xj; θ̂n
)
Yi (4)
where wt (T,X ; θ) = 1 {T = t}/ qt (x, θ) are the inverse probability weights (Ha´jek, 1971).
The main practical challenge with the described approach is that the reliability of
(4) depends on the model {qt (x, θt) , t ∈ T } for the generalized propensity score being
correctly specified. Although the aforementioned specifications are popular, they may be
too restrictive in some applications. If the working model for the generalized propensity
score is misspecified, causal effects estimators such as (4) are in general biased and policy
recommendations based on it can be highly misleading (Linden et al., 2016). To address
this issue, in this paper we propose new tests to assess whether the parametric putative
model for the generalized propensity score is correctly specified or not; that is, we seek
to test
H0 : P (E [e(t; θ
∗)|X ] = 0) = 1 for some θ∗ ∈ Θ ⊂ Rq and all t ∈ T , (5)
against
H1 : P (E [e(t; θ)|X ] = 0) < 1 for any θ ∈ Θ ⊂ Rq and/or some t ∈ T , (6)
where e(t; θ) ≡ 1(T = t)− qt(X, θ) is the parametrically specified generalized error, and
Θ ⊂ Rq is a compact parametric space with q ≥ 1 a given positive integer.
2.2 Specification tests based on double projections
The characterization of H0 and H1 in (5) and (6), respectively, makes explicit that test-
ing for whether the putative model for the generalized propensity score is correctly spec-
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ified or not can be seen as a special case of testing conditional moment restrictions
(Gonza´lez-Manteiga and Crujeiras, 2013). As argued by Escanciano (2006), (5) can be
equivalently characterized as
H0 : R
pro
t (β, u; θ
∗) = 0 almost everywhere
(
β⊤, u
)⊤ ∈ Πpro,
for some θ∗ ∈ Θ ⊂ Rq and all t ∈ T , (7)
where
Rprot (β, u; θ) ≡ E
[
e(t; θ)1
(
β⊤X ≤ u)] ,
and Πpro ≡ Sdx × [−∞,∞] denotes the projected space, with Sdx the unit sphere in Rdx ,
i.e., Sdx =
{
β ∈ Rdx : ||β|| = 1} with ||A|| = [tr (AA⊤)]1/2 denoting the Euclidean norm
for a generic matrix A.
The main motivations of expressing H0 as in (7) are that (i) R
pro
t (β, u; θ
∗) is based
on unconditional moment restrictions, implying that we can avoid the use of tuning
parameters such as bandwidths when estimating Rprot (β, u; θ
∗); and (ii) Rprot (β, u; θ
∗)
depends on covariates only through the one-dimensional projection β⊤X , greatly reducing
the dimensionality of the problem. Indeed, this dimension-reduction device has been
proven valuable in many contexts that need to deal with a large number of covariates;
see, e.g., Escanciano (2006), Garc´ıa-Portugue´s et al. (2014), Sun et al. (2017), Zhu et al.
(2017), and Kim et al. (2020); for an overview, see Guo and Zhu (2017). However, it is
worth mentioning that (7) involves not only a single process Rprot (β, u; θ
∗) as is commonly
the case in the specification testing literature (see Escanciano, 2008 for an exception),
but J different processes Rprot (β, u; θ
∗) associated with the treatment levels t.
From (7), one natural way to proceed is to compute the generalized residuals marked
empirical process based on the projections 1
(
β⊤X ≤ u),
Rpron,t (β, u; θ̂n) =
1√
n
n∑
i=1
ei(t; θ̂n)1(β
⊤Xi ≤ u),
(
β⊤, u
)⊤ ∈ Πpro,
where θ̂n is any
√
n-consistent estimator for θ∗, say θ̂mlen defined in (3), and ei(t; θ̂n) ≡
1(Ti = t) − qt(Xi, θ̂n), i = 1, . . . , n, are the parametric generalized residuals under H0.
Then, one use continuous functionals of Rpron,t to assess if H0 is rejected or not.
A potential drawback of following this path is that the underlying null limiting dis-
tribution of Rpron,t (β, u; θ̂n) depends on the estimator θ̂n . Indeed, as we shown in Lemma
A.1 in Appendix A, under H0 and certain regularity conditions including the smoothness
of qt (x, θ) with respect to θ and the
√
n-consistency behavior of θ̂n, R
pro
n,t
(
β, u; θ̂n
)
can
be decomposed as
Rpron,t (β, u; θ̂n) =
1√
n
n∑
i=1
ei(t; θ
∗)1(β⊤Xi ≤ u)
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−√n(θ̂n − θ∗)⊤E[gt(X, θ∗)1(β⊤X ≤ u)] + op(1), (8)
uniformly in
(
β⊤, u
)⊤ ∈ Πpro, for each t ∈ T , where gt(x, θ) ≡ ∂qt(x, θ)/∂θ for each
t ∈ T designates the score function associated with the parametric propensity score model
qt(x, θ) at the treatment level t. The asymptotic representation in (8) suggests that, for a
given parametric specification pt (x) = qt (x, θ
∗), t ∈ T , the asymptotic null distribution
of tests based on Rpron,t (β, u; θ̂n) will depend on whether one estimates θ
∗ using maxi-
mum likelihood, nonlinear least squares, or by the method of estimating equations, even
though the underlying specification for the generalized propensity score is the same across
these estimation methods. Furthermore, as noted by Escanciano (2006), tests based on
Rpron,t (β, u; θ̂n) also require that
√
n(θ̂n − θ∗) admits an asymptotically linear representa-
tion. Such a condition can be demanding, especially when one wishes to use estimation
methods that involve penalizations (Knight and Fu, 2000, Bu¨hlmann and van de Geer,
2011).
In light of these potential drawbacks, we follow an alternative route. More specifically,
our proposed test statistics are continuous functionals of the generalized residuals marked
empirical process based on the double-projections Pn,t1
(
β⊤X ≤ u),
Rdpron,t (β, u; θ̂n) ≡
1√
n
n∑
i=1
ei(t; θ̂n)Pn,t1(β⊤Xi ≤ u),
(
β⊤, u
)⊤ ∈ Πpro,
where the double-projected weight is
Pn,t1
(
β⊤X ≤ u) ≡ 1 (β⊤X ≤ u)− g⊤t (X, θ̂n)∆−1n,t(θ̂n)Gn,t(β, u; θ̂n), (9)
with
∆n,t(θ̂n) =
1
n
n∑
i=1
gt(Xi, θ̂n)g
⊤
t (Xi, θ̂n) and Gn,t(β, u; θ̂n) =
1
n
n∑
i=1
gt(Xi, θ̂n)1
(
β⊤Xi ≤ u
)
.
We label Pn,t1
(
β⊤X ≤ u) as a double-projection because, as it is evident from (9), it
involves first using the projection proposed by Escanciano (2006), 1
(
β⊤X ≤ u), and
then projecting 1
(
β⊤X ≤ u) onto the the tangent space of the nuisance parameters θ̂n
(Escanciano and Goh, 2014, Sant’Anna and Song, 2019). To the best of our knowledge,
this paper is the first to incorporate this double-projection argument, which, in practice,
translates to test statistics that are robust against the “curse of dimensionality” and
whose limiting null distributions are asymptotically invariant to θ̂n since, for each t ∈ T ,
E
[
gt(X, θ
∗)Pt1
(
β⊤X ≤ u)] ≡ 0,
almost everywhere in
(
β⊤, u
)⊤ ∈ Πpro, where
Pt1
(
β⊤X ≤ u) ≡ 1 (β⊤X ≤ u)− g⊤t (X, θ∗)∆−1t (θ∗)Gt(β, u; θ∗), (10)
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with ∆t(θ) = E
[
gt(X, θ)g
⊤
t (X, θ)
]
and Gt(β, u; θ) = E
[
gt(X, θ)1
(
β⊤X ≤ u)].
The intuition behind (10) is very simple. First of all, note that, for each t ∈ T ,(
β⊤, u
)⊤ ∈ Πpro, ∆−1t (θ∗)Gt (β, u; θ∗) is the vector of linear projection coefficients of
regressing 1
(
β⊤X ≤ u) on the score function gt(X, θ∗). Thus, it follows that
g⊤t (X, θ
∗)∆−1t (θ
∗)Gt (β, u; θ
∗)
is the best linear predictor of 1
(
β⊤X ≤ u) given gt(X, θ∗), and that (10) is nothing more
than the associated projection error, which, by definition, is orthogonal to gt(X, θ
∗). As
a consequence of (10), it follows that, under some weak regularity conditions, uniformly
in
(
β⊤, u
)⊤ ∈ Πpro,
Rdpron,t (β, u; θ̂n) =
1√
n
n∑
i=1
ei(t; θ
∗)Pt1(β⊤Xi ≤ u) + op(1),
for each t ∈ T ; see Theorem 1 in the next section. Thus, Rdpron,t (β, u; θ̂n) is asymptotically
invariant to the choice of the estimator θ̂n. In addition, the second projection also facili-
tates a simple multiplier bootstrap method to simulate accurately critical values of test
statistics based on Rdpron,t (β, u; θ̂n).
In order to operationalize our testing procedure, we need to choose a norm to measure
the distance of Rdpron,t (·) from zero. We propose using the Crame´r-von Mises-type test
statistic
CvMdpron =
∑
t∈T
an(t)
∫
Πpro
(
Rdpron,t (β, u; θ̂n)
)2
Fn,β(du) dβ, (11)
where, for each t, an(t) is a pre-specified (potentially random) non-negative weight func-
tion, Fn,β(u) = n
−1
∑n
i=1 1
(
β⊤Xi ≤ u
)
is the empirical distribution function of the one-
dimensional projected regressors
{
β⊤Xi
}n
i=1
for any fixed projected direction β ∈ Sdx ,
and dβ is the rescaled uniform density on the unit sphere Sdx . For the sake of practical
convenience, in Monte Carlo simulations in Section 5 and Empirical application in Sec-
tion 6, we simply use the constant weight an(t) ≡ 1 for all t ∈ T , though other sensible
choices are feasible, e.g., an(t) = n
−1
∑n
i=1 1(Ti = t).
At this stage, one may wonder why we have chosen to use a Crame´r-von Mises-type
instead of a Kolmogorov-Sminov-type test statistic. The reason is computational: as
we show below in Lemma 1, (11) can be written in a closed-form expression and does
not rely on any type of numerical integration method. As a direct consequence of these
attractive computational features is that (11) can be easily implemented even when X is
high-dimensional.
Lemma 1 Let CvMdpron be defined in (11) with S
dx the dx-dimensional unit sphere.
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Then, we have
CvMdpron =
∑
t∈T
an(t)
1
n2
n∑
i=1
n∑
j=1
n∑
r=1
eproi (t; θ̂n)e
pro
j (t; θ̂n)Aijr, (12)
with
eproi (t; θ̂n) = ei(t; θ̂n)− g⊤t (Xi, θ̂n)∆−1n,t(θ̂n)
1
n
n∑
s=1
gt(Xs, θ̂n)es(t; θ̂n), (13)
and
Aijr =
∫
Sdx
1
(
β⊤Xi ≤ β⊤Xr
)
1
(
β⊤Xj ≤ β⊤Xr
)
dβ = A
(0)
ijr
πdx/2−1
Γ (dx/2)
,
where Γ (·) is the gamma function, arccos is the inverse cosine function, and
A
(0)
ijr =

2π if Xi = Xr = Xj,
π if Xi = Xj, Xi = Xr or Xj = Xr,
π − arccos
(
(Xi −Xr)′ (Xj −Xr)
‖Xi −Xr‖ ‖Xj −Xr‖
)
otherwise.
Lemma 1 yields an explicit formula for our double-projected test-statistic CvMdpron . It
builds on Escanciano (2006) and Garc´ıa-Portugue´s et al. (2014), who derived expressions
for Crame´r-von Mises-type functionals of “single-projected” empirical processes akin to
Rpron,t (β, u; θ̂n). What is new in Lemma 1 is that it states that, instead of computing in-
finitely many projected residuals, one for each
(
β⊤, u
)⊤ ∈ Πpro as it is suggested by (9), it
suffices to use the sequence of projected parametric residuals
{
eproi (t; θ̂n), i = 1, . . . n, t ∈ T
}
as defined in (13), which does not depend on β. Also, we note that in implementing (12),
we can exploit the symmetry property Aijr = Ajir, and that
CvMdpron =
∑
t∈T
an(t)
1
n2
e˜pro(t; θ̂n)
⊤An e˜
pro(t; θ̂n),
where An = (
∑n
r=1Aijr)i,j is an n × n matrix and e˜pro(t; θ̂n) is the n × 1 vector of pro-
jected residuals, which further alleviates the computational cost (memory allocation) of
our proposed procedure (see Section 3.2 of Garc´ıa-Portugue´s et al., 2014). These compu-
tational tricks substantially improve the computational time and allow one to apply our
test to dataset with larger sample sizes. As we show in Section 4, they also help us on
implementing an easy-to-use multiplier bootstrap to compute critical values.
3 Asymptotic results
3.1 Asymptotic null distribution
In this section we investigate the limiting behavior of double-projected residuals marked
empirical process Rdpron,t (β, u; θ̂n) under the null hypothesis H0 in (5) and consequently that
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of test statistics CvMdpron based on it. We list all the relevant regularity conditions as
follows, which are standard. First, let us denote by FX(·) the marginal CDF of covariates
X . Also, let Ψpro(du, dβ) = Fβ(du)dβ. Recall that pt(x) = P(T = t|X = x), t ∈ T , are
the generalized propensity scores.
Assumption 1 The sample
{(
X⊤i , Ti
)⊤
, i = 1 . . . n
}
is a sequence of independent and
identically distributed (i.i.d.) random vectors from (X⊤, T )⊤ with ǫ < pt(x) < 1 − ǫ for
all x ∈ X and for each t ∈ T , for some small ǫ > 0.
Assumption 2 The propensity score model qt(X, θ) is twice continuously differentiable
in a neighborhood Θ0 of θ
∗ with Θ0 ⊂ Θ. The score function gt(X, θ) = ∂qt(X, θ)/∂θ
satisfies that there exists a FX(·)-integrable function M(·) such that supθ∈Θ0 ||gt(·, θ)|| ≤
M(·).
Assumption 3 (i) The parameter space Θ is a compact subset of Rq; (ii) the true pa-
rameter θ∗ belongs to the interior of Θ; and (iii) the estimator θ̂n satisfies
∣∣∣∣∣∣θ̂n − θ∗∣∣∣∣∣∣ =
Op(n
−1/2).
Assumption 4 The integrating function Ψpro(·) is absolutely continuous with respect to
the Lebesgue measure on Πpro.
To present our asymptotic results, henceforth, we adopt the following notation. For
a generic set G, let l∞ (G) be the Banach space of all uniformly bounded real functions
on G, equipped with the uniform metric ‖f‖
G
≡ supz∈G |f (z)|. We study the weak
convergence of Rdpron,t (β, u; θ̂n) and its related processes as elements of l
∞ (Πpro), where
Πpro ≡ Sdx × [−∞,∞] with Sdx the unit ball in Rdx . Let “⇒” denote weak conver-
gence on (l∞ (Πpro) ,B∞) in the sense of J. Hoffmann-Jφrgensen, where B∞ denotes the
corresponding Borel σ-algebra - see e.g. Definition 1.3.3 in van der Vaart and Wellner
(1996).
The generalized error is defined as ε(t) = 1(T = t) − pt(X). The following theorem
establishes the limiting null behavior of out test statistic CvMdpron .
Theorem 1 Suppose Assumptions 1–4 hold. Then, under the null hypothesis H0 in (5),
for any sequence an(t) = a(t) + op (1), with a(t) > 0 and 0 <
∑
t∈T a(t) ≤ C <∞,
CvMdpron
d−→ CvMdpro∞ ≡
∑
t∈T
a(t)
∫
Πpro
(
Rdpro∞,t (β, u)
)2
Ψpro (du, dβ) ,
where Rdpro∞,t is a Gaussian process with mean zero and covariance structure
K
dpro
t ((β, u) , (β
′, u′)) = E
[
σ2t (X)Pt1
(
β⊤X ≤ u)Pt1(β ′⊤X ≤ u′)] , (14)
where σ2t (X) = E [ε
2(t)|X ] = pt(X) (1− pt(X)) = qt(X, θ∗) (1− qt(X, θ∗)) is the condi-
tional variance function of generalized error ε(t) given X under the null.
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To prove Theorem 1, we first show that the limiting null behavior of Rdpron,t (β, u; θ̂n)
does not depend on θ̂n nor how θ̂n is obtained. Based on this result, we simply combine the
weak convergence of the doubly-projected empirical process Rdpron,t (·) with the continuous
mapping theorem (see, e.g., van der Vaart and Wellner, 1996, Theorem 1.3.6) to derive
the asymptotic distribution of our proposed Crame´r-von Mises test statistic, CvMdpron .
As is evident from Theorem 1, the asymptotic null distribution CvMdpro∞ depends
in a complicated manner on the underlying data generating process and thus critical
values of CvMdpro∞ are case-dependent. Thanks to the second projection introduced in
Rdpron,t
(
β, u; θ̂n
)
(i.e., the orthogonal projection onto the tangent space of the nuisance
parameters), we will be able to simulate as accurately as desired the critical values of
CvMdpro∞,J through a convenient multiplier bootstrap procedure, whose validity is guaran-
teed by Theorem 4 in Section 4.
3.2 Asymptotic power
In this section we study the asymptotic power properties of Rdpron,t (β, u; θ̂n) under the fixed
(i.e., global) alternative and a certain sequence of local alternatives converging to the null
at the parametric rate. We first consider the fixed alternative hypothesis H1 in (6).
Theorem 2 Suppose Assumptions 1–4 hold. Then, under the fixed alternative hypothesis
H1 in (6),
CvMdpron
n
p−→
∑
t∈T
a(t)
∫
Πpro
(
E
[
(pt (X)− qt (X, θ∗))Pt1
(
β⊤X ≤ u)])2 Ψpro (du, dβ) .
In Theorem 2, θ∗ should be understood as the limiting value of θ̂n, i.e., the pseudo-
true parameter under H1 in (6). It is also straightforward from Theorem 2 that under
the fixed alternative H1, as long as the unconditional expectation
E
[
(pt (X)− qt (X, θ∗))Pt1
(
β⊤X ≤ u)] 6= 0
for some (β, u) and for some treatment level t ∈ T , CvMdpron will diverge to positive
infinity at the n rate, indicating that CvMdpron is able to detect such fixed alternative
with probability tending to one.
On the other hand, Theorem 2 indicates that CvMdpron might not be consistent against
all fixed alternative hypotheses in (6) if E
[
(pt (X)− qt (X, θ∗))Pt1
(
β⊤X ≤ u)] = 0.
Specifically, the test statistic cannot distinguish those alternatives such that, for every
t ∈ T , the difference between pt(X) and qt(X, θ∗) is collinear to the score function
gt(X, θ
∗) associated with qt(X, θ
∗). However, given the nonlinear nature of the generalized
propensity score, we do not think this type of alternatives is of main practical concern.
Indeed, such a concern can be mechanically eliminated by estimating θ∗ using nonlinear
least squares.
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We now proceed to consider the asymptotic local power properties of our proposed
tests. Towards this end, we study the asymptotic distribution of Rdpron,t (β, u; θ̂n) under a
certain sequence of Pitman-type local alternatives converging to the null at a parametric
rate. In particular, we consider the data generating process for the sequence of local
alternatives given by
H1,n : P
[
pt(X) = qt(X, θ
∗) +
rt(X)√
n
]
= 1 for some θ∗ ∈ Θ ∈ Rq and all t ∈ T , (15)
where, for each t ∈ T , the direction of departure from H0 is given by function rt(X)
(potentially different for each t), which is assumed to be FX(·)-integrable with zero mean
and satisfy P (rt(X) = 0) < 1. Note that n
−1/2 signifies the rate of H1,n converging to
H0 as n increases, which is known as the fastest rate possible for specification tests to be
able to non-trivially detect local alternatives.
Theorem 3 Suppose Assumptions 1–4 hold. Then, under the sequence of local alterna-
tives H1,n in (15), we have that
CvMdpron
d−→ CvMdpro1,∞ ≡
∑
t∈T
a(t)
∫
Πpro
(
Rdpro∞,t (β, u) + δt (β, u)
)2
Ψpro (du, dβ) ,
where Rdpro∞,t is the same Gaussian process as defined in Theorem 1, and δt is a determin-
istic shift function given by
δt(β, u) = E
[
rt (X)Pt1
(
β⊤X ≤ u)] .
An immediate consequence of Theorem 3 is that, whenever there exists some t ∈ T
such that the deterministic shift function δt (β, u) 6= 0 for at least some (β, u) ∈ Πpro with
a positive Lebesgue measure, our proposed Crame´r-von Mises test statistic will have non-
trivial power in detecting local alternatives of the form (15). A pathological situation
in which our test will only have trivial local power against such alternatives is when
rt(X) is a linear combination of score function gt(X, θ
∗) for every treatment level t ∈ T ,
i.e., rt(X) = ν
⊤gt(X, θ
∗) a.s. for some nonzero vector ν. In such a case, the limiting
distribution of CvMdpron under H0 and H1,n is the same so that H1,n cannot be detected.
However, such a specific class of local alternatives is arguably of very limited practical
interest.
4 A multiplier bootstrap procedure
Since the limiting null distribution of our test statistic CvMdpron is non-pivotal, we propose
a simple-to-implement multiplier bootstrap procedure to approximate the null distribu-
tion and show its asymptotic validity. Below is its implementation:
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1. For each t ∈ T , i = 1, . . . n, generate e∗i (t; θ̂n) = Vi ei(t; θ̂n), where {Vi, i = 1, . . . , n}
is a sequence of independent and identically distributed random variables with mean
zero and variance one; e.g. Rademacher random variables (Liu, 1988) or Bernoulli
random variable with P (V = 1− κ) = κ/√5 and P (V = κ) = 1 − κ/√5, where
κ =
(
51/2 + 1
)
/2 (Mammen, 1993).
2. Compute
(
CvMdpro,∗n
)b
=
∑
t∈T
an(t)
1
n2
n∑
i=1
n∑
j=1
n∑
r=1
epro,∗i (t; θ̂n)e
pro,∗
j (t; θ̂n)Aijr,
where
epro,∗i (t; θ̂n) = e
∗
i (t; θ̂n)− g⊤t (Xi, θ̂n)∆−1n,t(θ̂n)
1
n
n∑
s=1
gt(Xs, θ̂n)e
∗
s(t; θ̂n).
3. Repeat steps 1 and 2 B times, and collect
{(
CvMdpro,∗n
)b
, b = 1 . . . , B
}
.
4. Obtain the (1− α)-th quantile of
{(
CvMdpro,∗n
)b
, b = 1 . . . , B
}
, c∗n,α, and set it as
the critical value for the test with significance level α, for 0 < α < 1.
5. Reject the null hypothesis (5) if CvMdpron is greater than the critical value c
∗
n,α, and
fail to reject (5) otherwise.
Note that CvMdpro,∗n can be computed as
CvMdpro,∗n =
∑
t∈T
an(t)
1
n2
e˜pro,∗(t; θ̂n)
⊤An e˜
pro,∗(t; θ̂n),
where An is defined before and e˜
pro,∗(t; θ̂n) is the n × 1 vector of
{
epro,∗i (t; θ̂n)
}n
i=1
. The
multiplier bootstrapped test statistic CvMdpro,∗n has attractive theoretical and empirical
properties. First, it does not require computing new parameter estimates at each boot-
strap draw, drastically reducing the computational intensity of the proposed procedure.
Second, thanks to the use of the double-projections, its implementation does not require
using estimators that admit an asymptotically linear representation. Third, thanks to
the closed-form representation in (12), Aijr, which is the most expensive in computation
time, does not need to be computed for each bootstrap sample. All these computational
aspects are particularly important when either the dimensionality dx of the pre-treatment
covariates X and/or the number of different treatment levels is large.
The next theorem establishes formally the asymptotic validity of the multiplier boot-
strap procedure described above. Let
Rdpro,∗n,t (β, u; θ̂n) =
1√
n
n∑
i=1
Vi ei(t; θ̂n)Pn,t1(β⊤Xi ≤ u),
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with Vi as described in step 1 above.
Theorem 4 Suppose Assumptions 1-4 hold. Then, we have CvMdpro,∗n
d→
∗
CvMdpro∞ with
probability one under the bootstrap law, where CvMdpro∞ is the same distribution as defined
in Theorem 1, and
d→
∗
denotes weak convergence under the bootstrap law, i.e., conditional
on the original sample
{
(Ti, X
⊤
i )
⊤
}n
i=1
.
Theorem 4 states that the bootstrapped statistic CvMdpro,∗n converges to the null lim-
iting distribution of CvMdpron conditional on the original sample. The fact that CvM
dpro,∗
n
has the same limiting distribution under H0, H1, and H1,n is what allows the proposed
procedure to work.
Remark 1 It is worth noting that, when the dependent variable is discrete (e.g., Ti in our
context of multi-valued treatment effects), the multiplier bootstrap is always meaningful
as it does not require to generate bootstrap sample. On the other hand, in this particular
context, the classical residual-based wild bootstrap such as the one used by Escanciano
(2006) would generate bootstrapped dependent variables that are no longer discrete and
thus fail to mimic the original data structures. A potential alternative to circumvent
this drawback faced by the classical residual-based wild bootstrap is to use the parametric
bootstrap, which, however, is much more computationally expensive because one needs to
compute new parameter estimates at each bootstrap draw. When the number of covariates
and/or the number of treatment levels is relatively high, such a procedure tends to be very
time consuming.
5 Monte Carlo simulations
In this section, we conduct a series of Monte Carlo experiments to study the finite sample
properties of the double projection-based tests in the context of observational treatment
effect studies. We consider three different setups with (i) a binary treatment, (ii) multino-
mial, unordered treatments (henceforth multinomial treatments), and (iii) multinomial,
ordered treatments (henceforth ordered treatments). For the sake of space, we defer the
discussion of ordered treatments to Appendix B.
Given that the simulation results in Sant’Anna and Song (2019) indicate that their
test dominate several others in terms of size and power in the binary treatment setup,
we only compare our Crame´r-von Mises tests CvMdpron given in (12) to their Crame´r-von
Mises test. For the ordered and multinomial treatment setups, we consider extensions of
the Sant’Anna and Song (2019)’s projection-based tests that are able to accommodate
multi-valued treatment variables.
Critical values for the CvMdpron test statistic are obtained using the multiplier boot-
strap procedure described in Section 4, whereas for the single projection-based tests we
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use the multiplier bootstrap procedure described in Sant’Anna and Song (2019). We
consider sample sizes n equal to 200, 400, and 800. For each design, we consider 1, 000
Monte Carlo experiments. The {Vi, i = 1, . . . , n} used in the bootstrap implementations
are independently generated as V with P (V = 1− κ) = κ/√5 and P (V = κ) = 1−κ/√5,
where κ =
(√
5 + 1
)
/2, as proposed by Mammen (1993). The bootstrapped critical val-
ues are approximated using B = 999 bootstrap replications. In all simulations, we use
constant weight an(t) ≡ 1 for all t ∈ T in both CvMdpron and CvMdpro,∗n .
5.1 Simulation 1: Binary treatment
We first consider the binary treatment case with J = 1. Consider the following data
generating processes (DGPs), which are similar to Sant’Anna and Song (2019):
DGP1. T ∗ = −
∑10
j=1Xj
6
− ε;
DGP2. T ∗ = −1−
∑10
j=1Xj
10
+
X1X2
2
− ε;
DGP3. T ∗ = −1−
∑10
j=1Xj
10
+
X1
∑5
k=2Xk
4
− ε;
DGP4. T ∗ = −1.5−
∑10
j=1Xj
6
+
∑10
k=1X
2
k
10
− ε;
DGP5. T ∗ =
−0.1 + 0.1∑5j=1Xj
exp
(−0.2∑10k=1Xj) − ε.
For each of these five DGPs, T = 1 {T ∗ > 0} , ε ⊥ X , with X = (1, X1, X2, . . . , X10)⊤
where X1 = Z1, X2 = (Z1 + Z2) /
√
2, Xk = Zk, k = 3, . . . , 10, and {Zk}10k=3 and ε are
independent standard normal random variables. For each of these DGPs we consider the
following potential outcomes:
Y (1) = 2m1(X) + u (1) and Y (0) = m1 (X) + u (0) ,
where m1 (X) = 1 +
∑10
j=1Xj , u (1) and u (0) are independent normal random variables
with mean zero and variance 1. The observed outcome is Y = TY (1)+(1− T )Y (0), and
the true average treatment effect (ATE) is 1. Although these outcome equations are not
necessary to assess the size and power properties of the tests, they can be used to assess
the utility of our proposed tests to distinguish between “good” and “bad” estimates of
the ATE.
For DGP1−DGP5, the null H0 considered is
H0 : ∃θ∗ = (δ0, δ1, . . . , δ10)⊤ ∈ Θ : E [T |X ] = Φ
(
X⊤θ∗
)
a.s., (16)
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where Φ(·) is the CDF of the standard normal distribution. We estimate θ∗ using the
probit maximum likelihood, i.e.,
θ̂n = argmax
θ∈Θ
n∑
i=1
Ti ln
(
Φ
(
X⊤i θ
))
+ (1− Ti) ln
(
1− Φ (X⊤i θ)) .
Clearly, DGP1 falls under H0, whereas DGP2−DGP5 fall under H1, i.e., the negation of
(16). Note that the treatment status T follows a heteroskedastic probit model in DGP5.
We compare the performance of our proposed test statistic CvMdpron in (12) based on
double projections with Sant’Anna and Song (2019)’s Crame´r-von Mises test
CvMssn =
1
n
n∑
i=1
(
Rssn
(
q
(
Xi, θ̂n
)))2
, (17)
with q
(
Xi, θ̂n
)
= Φ
(
X⊤i θ̂n
)
, Rssn (u) ≡ n−1/2
∑n
j=1 ej(θ̂n)Pn1
(
q(Xj, θ̂n) ≤ u
)
,
Pn1 (q(X, θ) ≤ u) = 1 (q(X, θ) ≤ u)− g⊤(X, θ)∆−1n (θ)Gn (u, θ) ,
e(θ) = T − q (X, θ), g(x, θ) = ∂q(x, θ)/∂θ, Gn(u, θ) = n−1
∑n
i=1 g(Xi, θ)1 (q(Xi, θ) ≤ u),
and ∆n (θ) = n
−1
∑n
i=1 g(Xi, θ)g
⊤(Xi, θ).
The simulation results are presented in Table 1. We report empirical rejection fre-
quencies at the 5% significance level. Results for 10% and 1% significance levels are
similar and are available upon request. We also report the bias, root mean squared error
(RMSE), and coverage of the 95% confidence interval of the stabilized inverse probability
weighted estimator
ATEn =
1
n
n∑
i=1
(
wi,1
w¯n,1
− wi,0
w¯n,0
)
Yi, (18)
where wi,1 = Ti/q
(
Xi, θ̂n
)
, wi,1 = (1− Ti) /
(
1− q
(
Xi, θ̂n
))
, and w¯n,t is the sample
mean of wi,t for t = 0, 1. The 95% confidence interval is estimated via the percentile
bootstrap with 499 draws.
We first analyze the size of our test. From the results of DGP1, we find that the
actual finite sample size of both CvMdpron and CvM
ss
n tests is close to their nominal size,
even when the sample size is as small as 200. In addition, note that when the propensity
score is correctly specified, the bias of the ATEn estimator in (18) is small, and the
coverage probability is close to its nominal value even when n = 200.
Note that when the propensity score is misspecified in DGP2-DGP5, the ATE esti-
mator (18) can be severely biased and its 95% confidence interval too liberal, i.e., it can
severely undercover the true ATE. Thus, tests with higher power to detect such model
misspecifications can prevent one to make misleading conclusions about the effectiveness
of a given policy. Our proposed CvMdpron test perform admirably well in such a task.
Perhaps, what is more important to emphasize in terms of power is that in all alterna-
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Table 1: Monte Carlo results under designs DGP1-DGP5: Binary Treatment
DGP n CvMdpron CvM
ss
n Bias RMSE COV
1 200 0.060 0.057 -0.085 0.623 0.964
1 400 0.053 0.056 -0.007 0.504 0.950
1 800 0.053 0.054 -0.006 0.381 0.934
2 200 0.648 0.154 0.582 1.301 0.983
2 400 0.990 0.264 0.613 0.958 0.901
2 800 1.000 0.495 0.589 0.709 0.663
3 200 0.356 0.183 1.106 1.768 0.978
3 400 0.885 0.465 1.359 1.764 0.710
3 800 0.999 0.799 1.330 1.530 0.254
4 200 0.368 0.151 0.603 1.619 0.978
4 400 0.856 0.304 0.963 1.772 0.948
4 800 1.000 0.576 1.031 1.424 0.719
5 200 0.123 0.100 -0.106 0.358 0.976
5 400 0.265 0.192 -0.105 0.244 0.948
5 800 0.590 0.502 -0.118 0.192 0.899
Note: Simulations based on 1,000 Monte Carlo experiments. “CvMdpron ”
stands for our proposed double-projected Crame´r-von Mises test in (12).
“CvM ssn ” stands for Sant’Anna and Song (2019)’s test defined in (17). Finally,
“Bias”, “RMSE” and “COV” stand for the average simulated bias, average
simulated root mean squared error, and 95% coverage probability for the ATE
estimator ATEn as defined in (18). The 95% coverage probability is based on
the percentile bootstrap with 499 draws. See the main text for further details.
tive hypotheses and sample sizes analyzed, our CvMdpron test has substantial higher power
than Sant’Anna and Song (2019)’s CvMssn test. For instance, in DGP2 with n = 200, our
proposed test is four times more powerful than Sant’Anna and Song (2019)’s test, which
is already more powerful than other tests available in the literature including covariate
balancing tests and traditional specification test based on kernel method; see Section 4.2
of Sant’Anna and Song (2019) for additional details.
5.2 Simulation 2: Multinomial treatments
In this section we consider unordered, multinomial treatments. Our DGPs are similar to
Yang et al. (2016). The covariates X1, X2, X3 are generated from a multivariate normal
distribution with mean zero, variances of (2, 1, 1) and covariances of (1,−1,−0.5); X4
follows a uniform distribution from −3 to 3; X5 follows a chi-squared distribution with
one degree of freedom; and X6 follows a Bernoulli distribution with p = 0.5. Let X =
(X1, . . . , X6)
⊤. We consider three treatment groups, T = {0, 1, 2}, whose assignment
mechanism follows the multinomial logistic model
(T0, T1, T2) |X ∼Multinomial (p0 (X) , p1 (X) , p2 (X) ,
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where Tt is the treatment indicator, i.e., Tt = 1 (T = t), and for t = 0, 1, 2,
pt (X) =
exp (φt (X))∑2
s=0 exp (φs (X))
.
In what follows, we take φ0 (X) = 0 and vary φ1 (X) and φ2 (X) as follows:
DGP6. φ1 (X) = −1 + 0.4
6∑
j=1
Xj , φ2 (X) = −1 + 0.2
6∑
j=1
Xj;
DGP7. φ1 (X) = −0.2
6∑
j=1
Xj +X1X6, φ2 (X) = −0.1
6∑
j=1
Xj +X1X4;
DGP8. φ1 (X) = 0.3
6∑
j=1
Xj, φ2 (X) = −0.5 + 0.1
6∑
j=1
X2j ;
DGP9. φ1 (X) = −0.1 +
∑6
j=1Xj
5
+
X6
∑3
l=1Xl
2
, φ2 (X) = −0.3
6∑
j=1
Xj − X6 (X4 +X5)
2
;
DGP10. φ1 (X) = sin
(
6∑
j=1
Xj
)
+
3∑
l=1
Xl, φ2 (X) = 2 sin
(
6∑
j=1
Xj
)
+
1
2
3∑
l=1
Xl.
For each of these DGPs we consider the potential outcomes
Y (0) = 1+X⊤β0+u (0) , Y (1) = 20+X
⊤β1+u (1) , and Y (2) = 6+X
⊤β2+u (2) ,
where u (0), u (1) and u (2) are independent normal random variables with mean zero
and variance 1, β0 = (−6,−6,−6, 6, 6, 6)⊤, β1 = −β0, and β2 = 4. The observed outcome
is Y = 1 (T = 0)Y (0) + 1 (T = 1) Y (1) + 1 (T = 2)Y (2), and the true ATE1,0 = 1,
ATE2,0 = 2, and ATE2,1 = 1.
Let α = (α1, α2)
⊤ and δ =
(
δ⊤1 , δ
⊤
2
)⊤
. For DGP6−DGP0, the H0 considered is
H0 : ∃θ∗ = (α⊤, δ⊤)⊤ ∈ Θ : P (T = t|X) =
exp
(
αt +X
⊤δt
)∑2
s=0 exp (αs +X
⊤δs)
a.s., for t = 1, 2,
(19)
where, with some abuse of notation, we set α0 = δ0 = 0. We estimate θ
∗ using the
multinomial logit likelihood, i.e.
θ̂n = argmax
θ∈Θ
n∑
i=1
2∑
t=0
[
Ti,t · ln
(
exp
(
αt +X
⊤
i δt
)∑2
s=0 exp
(
αs +X⊤i δs
))] ,
Clearly, DGP6 falls under H0, whereas DGP7−DGP10 fall under H1, i.e., the negation
of (19).
In the multinomial setup, our proposed test statistic CvMdpron is given by (12) with
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an (1) = an (2) = 1, ei
(
t; θ̂n
)
= 1 (Ti = t)− qt
(
Xi, θ̂n
)
,
qt
(
Xi, θ̂n
)
= Λmt (Xi, θ) =
exp
(
αt +X
⊤
i δt
)∑2
s=0 exp
(
αs +X⊤i δs
) ,
and the score defined accordingly.
Although Sant’Anna and Song (2019) only considered specification tests for binary
treatments, we note that their tests can be extended to test (19). We consider two
different extensions of Sant’Anna and Song (2019)’s specification tests. The first variant
of Sant’Anna and Song (2019)’s test statistic is given by
CvMss1,mn = CvM
ss1,m
n,1 + CvM
ss1,m
n,2 , (20)
where, for t = 1, 2, CvMss1,mn,t = n
−1
∑n
i=1
(
Rss1,mn,t
(
q1
(
Xi, θ̂n
)
, q2
(
Xi, θ̂n
)))2
, with
Rss1,mn,t (u1, u2) ≡
1√
n
n∑
j=1
ej(t; θ̂n)Pn,t
(
1
(
Λm1
(
Xi, θ̂n
)
≤ u1
)
1
(
Λm2
(
Xi, θ̂n
)
≤ u2
))
,
and
Pn,t (1 (Λm1 (X, θ) ≤ u1) 1 (Λm2 (X, θ) ≤ u2)) =
1 (Λm1 (X, θ) ≤ u1) 1 (Λm2 (X, θ) ≤ u2)− g⊤t (X, θ)∆−1n,t (θ)Gmn,t (u1, u2; θ) ,
gt(X, θ) and ∆
−1
n,t (θ) being defined as before, and
Gmn,t (u1, u2; θ) =
1
n
n∑
i=1
gt(Xi, θ)1 (Λ
m
1 (X, θ) ≤ u1) 1 (Λm2 (X, θ) ≤ u2) .
The second variant of Sant’Anna and Song (2019) test statistic is given by
CvMss2,mn = CvM
ss2,m
n,1 + CvM
ss2,m
n,2 , (21)
where, for t = 1, 2, CvMss2,mn,t = n
−1
∑n
i=1
(
Rss2,mn,t
(
Λmt
(
Xi, θ̂n
)))2
, and
Rss2,mn,t (u) ≡
1√
n
n∑
j=1
ej(t; θ̂n)Pn,t1
(
Λmt
(
Xj, θ̂n
)
≤ u
)
,
with Pn,t1 (Λmt (X, θ) ≤ u) = 1 (Λmt (X, θ) ≤ u)− g⊤t (X, θ)∆−1n,t (θ)Gn,t (u, θ), and gt(x, θ),
Gn,t(u, θ) and ∆n,t (θ) defined analogously to the binary treatment setup.
It is important to emphasize that (20) and (21) are test statistics for implications of
(19), and not for (19) itself. More precisely, (20) is a test statistic for the null hypothesis
H ′0 : ∃θ∗ = (α⊤, δ⊤)⊤ ∈ Θ : E [em(t; θ∗)|Λm1 (X, θ∗) ,Λm2 (X, θ∗)] = 0 a.s. for t = 0, 1.
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whereas (21) is a test statistic based on the null hypothesis
H
′′
0 : ∃θ∗ = (α⊤, δ⊤)⊤ ∈ Θ : E [em(t; θ∗)|Λmt (X, θ∗)] = 0 a.s. for t = 0, 1,
Importantly and in sharp contrast to CvMdpron , both CvM
ss1,m
n and CvM
ss2,m
n are not
consistent against general nonparametric alternatives H1 in (6).
The simulation results are presented in Table 2. We report empirical rejection fre-
quencies at the 5% significance level. We also report the bias, RMSE, and coverage of
the 95% confidence interval of the stabilized inverse probability weighted estimators
ATEn,j,ℓ =
1
n
n∑
i=1
(
wi,j
w¯n,j
− wi,ℓ
w¯n,ℓ
)
Yi, (22)
where
wi,0 =
1 {Ti = 0}
q0
(
Xi, θ̂n
) , wi,1 = 1 {Ti = 1}
q1
(
Xi, θ̂n
) , wi,2 = 1 {Ti = 2}
q2
(
Xi, θ̂n
) ,
and w¯n,t is the sample mean of wi,t, t = 0, 1, 2. The 95% confidence interval is estimated
via the percentile bootstrap with 499 draws.
Table 2: Monte Carlo results under designs DGP6-DGP10: Multinomial Treatment
DGP n CvMdpron CvM
ss1,m
n CvM
ss2,m
n Bias1,0 Bias2,0 RMSE1,0 RMSE2,0 COV1,0 COV2,0
6 200 0.057 0.064 0.054 0.183 0.097 3.232 2.131 0.951 0.975
6 400 0.059 0.058 0.055 -0.048 -0.019 2.337 1.614 0.940 0.962
6 800 0.057 0.056 0.056 0.012 -0.019 1.739 1.254 0.941 0.939
7 200 0.992 0.206 0.296 0.251 2.115 3.300 2.822 0.947 0.852
7 400 1.000 0.427 0.502 -0.040 2.042 2.401 2.378 0.944 0.620
7 800 1.000 0.708 0.712 -0.004 2.038 1.507 2.197 0.960 0.264
8 200 0.467 0.076 0.146 1.205 1.246 3.128 2.414 0.927 0.913
8 400 0.827 0.089 0.262 0.854 1.061 2.195 1.735 0.916 0.858
8 800 0.993 0.144 0.478 0.864 1.014 1.585 1.370 0.899 0.765
9 200 0.084 0.063 0.074 0.412 -1.082 3.419 3.755 0.950 0.864
9 400 0.171 0.061 0.113 0.562 -0.422 2.181 3.538 0.954 0.828
9 800 0.269 0.071 0.147 0.491 0.100 1.597 3.543 0.928 0.850
10 200 0.146 0.095 0.081 -0.481 -1.421 4.406 3.024 0.956 0.877
10 400 0.282 0.159 0.142 -0.766 -1.258 3.640 2.338 0.930 0.773
10 800 0.746 0.342 0.289 -0.814 -1.213 2.482 1.836 0.927 0.695
Note: Simulations based on 1,000 Monte Carlo experiments. “CvMdpron ” stands for our proposed Crame´r-von Mises
tests (12). “CvM ss1,mn ” and “CvM
ss2,m
n ” stand for extensions of Sant’Anna and Song (2019)’s test defined in (20) and
(21), respectively. Finally, “Biask,s”, “RMSEk,s” and “COVk,s” stand for the average simulated bias, average simu-
lated root mean squared error, and 95% coverage probability for the ATEk,s estimator ATEn,k,s as defined in (22). The
95% coverage probability is based on the percentile bootstrap with 499 draws. See the main text for further details.
As before, we first discuss the size properties of the tests. From the results of DGP6,
we find that all considered tests have good size properties and the IPW estimators for
the average treatment effects have little to no bias, their RMSE decrease with sample
size, and their coverage probability is very close to the nominal level.
In terms of power, note that, under DGP7-10, our proposed double-projection test
CvMdpron outperform both CvM
ss1,m
n and CvM
ss2,m
n in all considered scenarios by a sig-
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nificant margin. We note that CvMss2,mn tends to outperform CvM
ss1,m
n in all DGPs,
except DGP10. Finally, it is evident from Table 2 that generalized propensity score
misspecification can indeed lead to misleading conclusions about the treatment effect
effectiveness.
Overall, our simulation results highlight that the proposed projection-based tests per-
form favorably compared to other alternative testing procedures. Importantly, the simu-
lations illustrate that our proposed tests are suitable to setups with many covariates, and
that the gains in power when compared to other alternatives can be substantial. Given
these attractive features, we believe that our tests can be of great use in practice.
6 Data illustration
In this section, we apply our tests to analyze the goodness-of-fit of different generalized
propensity score models used to study the effect of maternal smoking on birth weight.
The dataset, available at http://www.stata-press.com/data/r13/cattaneo2.dta, is
the excerpt from Almond et al. (2005) and Cattaneo (2010) previously used by Lee et al.
(2017). It consists of observations from white mothers in Pennsylvania in the USA; like
Lee et al. (2017), we further restrict our sample to white and non-Hispanic mothers,
totally 3, 754 observations. The treatment variable, T , is a multi-valued variable that is
equal to 0 if the mother does not smoke during the pregnancy, equal to 1 if the mother
smokes, on average, between one and five cigarettes a day during the pregnancy, equal
to 2 if the mother smokes, on average, between six and ten cigarettes a day during the
pregnancy, and equal to 3 if the mother smokes, on average, more than eleven cigarettes a
day during the pregnancy. The set of pre-treatment covariates X we use are mother’s age,
number of prenatal care visits, and indicator variables for alcohol consumption during
pregnancy, first prenatal visit in the first trimester, whether there was a previous birth
where the newborn died, twelve years of education (complete high-school), and more
than twelve years of educations (some college). The outcome of interest is the infant
birth weight measured in grams.
We start our analysis by analyzing the effect of the mother being a smoker during
the pregnancy (T > 0) versus not smoking during the pregnancy (T = 0). Given the
binary nature of the “being a smoker” treatment, we estimate the propensity score using
a logistic regression model with linear predictors including all aforementioned covariates.
We then apply our proposed specification test to assess the goodness-of-fit of this simple
propensity score model, using 9, 999 bootstrap replications. Our procedure yields a p-
value of 0.18, suggesting that our proposed testing procedure does not find any evidence
of model misspecification at the usual significance levels.
Next, we move our attention to analyzing the effect of maternal smoking intensity
during pregnancy, T . Given that the treatment T is clearly ordered, we estimate the
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Table 3: Results from the empirical illustration: point estimates, standard error by the
bootstrap, and 95% confidence interval
Point Estimate Standard Error 95% Confidence Interval
(a) The causal effect of mother being a smoker during pregnancy on infant’s birth weight
Estimators based on a logit propensity score model
E [Y (1)− Y (0)] -270 28 (-326, -215)
(b) The causal effect of mother’s smoking intensity during pregnancy on infant’s birth weight
Estimators based on an ordered logit generalized propensity score model
E [Y (1)− Y (0)] -279 59 (-401, -164)
E [Y (2)− Y (0)] -244 46 (-338, -156)
E [Y (3)− Y (0)] -279 39 (-357, -202)
(c) The causal effect of mother’s smoking intensity during pregnancy on infant’s birth weight
Estimators based on a multinomial logit generalized propensity score model
E [Y (1)− Y (0)] -250 49 (-346, -154)
E [Y (2)− Y (0)] -241 49 (-338, -148)
E [Y (3)− Y (0)] -267 42 (-347, -184)
Note: Standard errors computed using the empirical bootstrap with 9,999 draws. 95% confidence intervals based on
the percentile bootstrap with 9,999 draws. See the main text for further details.
generalized propensity score using an ordered logit regression model with all covariates
entering the model in a linear fashion. Although natural, we note that the ordered logit
model imposes important restrictions on the data such as a proportional odds restriction.
In practice, however, such restrictions may be too rigid for a given application. Indeed,
our proposed specification test with 9, 999 bootstrap replications yield a p-value of 0.08,
suggesting that the ordered logit model is misspecified at the 10% significance level.
A relatively straightforward way to relax the proportional odd restrictions inherited
in the ordered logit model is to ignore that the treatment T is ordered and estimate the
generalized propensity score using a multinomial logit linear regression model. In contrast
with the ordered logit model, the multinomial logit model does not impose that the
regressors coefficients are the same across different treatment levels. Our specification test
with 9, 999 bootstrap replications yield a p-value of 0.72, suggesting that the multinomial
logit model is a more suitable model for maternal smoking intensity during pregnancy T
than the order logit model.
Table 3 shows the estimates of the causal effects of smoking on birth weight based
on the inverse probability weighting estimators for binary and multi-valued treatments,
ATEn as in (18) and ATEn,j,ℓ as in (22), respectively. Although qualitatively similar, one
can notice some differences on the standard errors and confidence intervals between the
treatment effects estimates based on misspecified ordered logit model and those based on
the multinomial logit model for the generalized propensity score. This illustrates one of
the potential pitfalls of model misspecification.
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7 Conclusion
In this article, we proposed a new class of specification tests for generalized propen-
sity score models based on a novel double-projected weight functions. We have shown
that the use of double projections helps ameliorate the “curse of dimensionality” and
avoids the complications associated with “parameter estimation uncertainty” commonly
encounter in specification testing with moderate or high-dimensional covariates. We have
also shown that our proposed test statistics can be written in closed-form, and that one
can use an easy-to-implement multiplier bootstrap procedure to compute critical values as
accurately as desired. The simulation results and the empirical application highlight that
our proposed tests can serve as a valuable diagnostic tool in the context of multivalued
treatment effects.
Although we focused on the generalized propensity score models, we note that our
proposed methodology can be readily used in other contexts, too. For instance, one can
use our double-projection procedure to test if a given parametric regression model is
correctly specified, i.e., to test
Hreg0 : P [m(X) = f(X, θ0)] = 1 for some θ0 ∈ Θ ⊂ Rq,
Hreg1 : P [m(X) = f(X, θ)] < 1 for any θ ∈ Θ ⊂ Rq,
where m(X) = E [Y |X ] is the true regression function, and f(X, θ) is a parametric
specification for m(X). We also anticipate that one can extend our proposal to test
whether a putative (nonlinear) quantile or distribution regression are correctly specified;
see, e.g., Rothe and Wied (2013) and Escanciano and Goh (2014). We leave a detailed
analysis of this extension for future research.
Appendix A: Mathematical proofs
Proof of Lemma 1: For simplicity, let us consider J = 1 (the binary treatment case)
and thus omit the dependence on t. The general case with J ≥ 2 follows readily. First,
recall the definition of projection operator Pn1
(
β⊤Xi ≤ u
)
. By simple algebra,
CvMdpron =
1
n2
n∑
i=1
n∑
j=1
n∑
r=1
ei(θ̂n)ej(θ̂n)
∫
Sdx
Pn1
(
β⊤Xi ≤ β⊤Xr
)Pn1 (β⊤Xj ≤ β⊤Xr) dβ
=
1
n2
n∑
i=1
n∑
j=1
n∑
r=1
ei(θ̂n)ej(θ̂n)
∫
Sdx
1
(
β⊤Xi ≤ β⊤Xr
)
1
(
β⊤Xj ≤ β⊤Xr
)
dβ
− 2 1
n3
n∑
i=1
n∑
j=1
n∑
r=1
n∑
s=1
ei(θ̂n)ej(θ̂n)g
⊤(Xj , θ̂n)∆
−1
n (θ̂n)g(Xs, θ̂n)
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×
∫
Sdx
1
(
β⊤Xi ≤ β⊤Xr
)
1
(
β⊤Xs ≤ β⊤Xr
)
dβ
+
1
n4
n∑
i=1
n∑
j=1
n∑
r=1
n∑
s=1
n∑
t=1
ei(θ̂n)ej(θ̂n)g
⊤(Xj, θ̂n)∆
−1
n (θ̂n)g(Xs, θ̂n))
× g⊤(Xj, θ̂n)∆−1n (θ̂n)g(Xs, θ̂n)
∫
Sdx
1
(
β⊤Xs ≤ β⊤Xr
)
1
(
β⊤Xt ≤ β⊤Xr
)
dβ
:=Bn1 − 2Bn2 +Bn3.
As in Escanciano (2006), if denoting Aijr =
∫
Sdx
1
(
β⊤Xi ≤ β⊤Xr
)
1
(
β⊤Xj ≤ β⊤Xr
)
dβ,
we have that
Bn1 =
1
n2
n∑
i=1
n∑
j=1
n∑
r=1
ei(θ̂n)ej(θ̂n)Aijr,
Bn2 =
1
n3
n∑
i=1
n∑
j=1
n∑
r=1
n∑
s=1
ei(θ̂n)ej(θ̂n)g
⊤(Xj, θ̂n)∆
−1
n (θ̂n)g(Xs, θ̂n)Aisr
=
1
n3
n∑
i=1
n∑
j=1
n∑
r=1
ei(θ̂n)
[
g⊤(Xj, θ̂n)∆
−1
n (θ̂n)
1
n
n∑
s=1
g(Xs, θ̂n)es(θ̂n)
]
Aijr,
where the second equality follows by letting j = s, and
Bn3 =
1
n4
n∑
i=1
n∑
j=1
n∑
r=1
n∑
s=1
n∑
t=1
ei(θ̂n)ej(θ̂n)g
⊤(Xj , θ̂n)∆
−1
n (θ̂n)g(Xs, θ̂n))
g⊤(Xj, θ̂n)∆
−1
n (θ̂n)g(Xs, θ̂n)Astr
=
1
n2
n∑
i=1
n∑
j=1
n∑
r=1
[
g⊤(Xi, θ̂n)∆
−1
n (θ̂n)
1
n
n∑
s=1
g(Xs, θ̂n)es(θ̂n)
]
[
g⊤(Xj, θ̂n)∆
−1
n (θ̂n)
1
n
n∑
t=1
g(Xt, θ̂n)et(θ̂n)
]
Aijr,
where the second equality follows by letting i = s and j = t.
As a result,
CvMdpron =
1
n2
n∑
i=1
n∑
j=1
n∑
r=1
[
ei(θ̂n)− g⊤(Xi, θ̂n)∆−1n (θ̂n)
1
n
n∑
s=1
g(Xs, θ̂n)es(θ̂n)
]
[
ej(θ̂n)− g⊤(Xj , θ̂n)∆−1n (θ̂n)
1
n
n∑
t=1
g(Xt, θ̂n)et(θ̂n)
]
Aijr
=
1
n2
n∑
i=1
n∑
j=1
n∑
r=1
eproi (θ̂n)e
pro
j (θ̂n)Aijr.
This completes the proof of Lemma 1. 
The proof of Theorem 1 is very similar to the proofs of Theorem 1 and Corollary 1
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in Sant’Anna and Song (2019). For the sake of completeness, in the following we give
its proof. Towards this end, we first need to introduce several auxiliary lemmas. The
next lemma establishes the uniform asymptotic decomposition of the “once” projected
empirical process
Rpron,t (β, u; θ̂n) =
1√
n
n∑
i=1
ei(t; θ̂n)1(β
⊤Xi ≤ u),
(
β⊤, u
)⊤ ∈ Πpro.
Lemma A.1 Suppose Assumptions 1–3 hold. Then, for each t ∈ T , we have that
sup
(β,u)∈Πpro
∣∣∣∣∣Rpron,t (β, u; θ̂n)− 1√n
n∑
i=1
ei(t; θ
∗)1(β⊤Xi ≤ u) +
√
n(θ̂n − θ∗)⊤Gt(β, u; θ∗)
∣∣∣∣∣ = op(1),
where Gt(β, u; θ) = E[gt(X, θ)1(β
⊤X ≤ u)].
Proof of Lemma A.1: Observe that, for each t,
Rpron,t (β, u; θ̂n)
=
1√
n
n∑
i=1
ei(t; θ
∗)1(β⊤Xi ≤ u)− 1√
n
n∑
i=1
(qt(Xi, θ̂n)− qt(Xi, θ∗))1(β⊤Xi ≤ u).
By the Mean Value Theorem (MVT) and Assumptions 2–3, the second term in the
previous expression is simply
−√n(θ̂n − θ∗)⊤ 1
n
n∑
i=1
∂qt(Xi, θ˜n)
∂θ
1(β⊤Xi ≤ u)
=−√n(θ̂n − θ∗)⊤E
[
gt(X, θ
∗)1(β⊤Xi ≤ u)
]
+ op(1),
with θ˜n lying between θ̂n and θ
∗, where the latter equality follows by the uniform law of
large numbers (ULLN) of Newey and McFadden (1994, Lemma 2.4). This finishes the
proof of Lemma A.1. 
Now, for each t ∈ T , introduce the following auxiliary quantity,
Sn,t =
1√
n
n∑
i=1
ei(t; θ̂n)gt(Xi, θ̂n).
Lemma A.2 Suppose Assumptions 1–3 hold. Then, under the null hypothesis H0 in (5),
for each t ∈ T , we have that
Sn,t =
1√
n
n∑
i=1
ei(t; θ
∗)gt(Xi, θ
∗)−∆t(θ∗)
√
n(θ̂n − θ∗) + op(1),
where ∆t(θ) = E
[
gt(X, θ)g
⊤
t (X, θ)
]
.
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Proof of Lemma A.2: We can rewrite Sn,t as
Sn,t =
1√
n
n∑
i=1
ei(t; θ
∗)gt(Xi, θ
∗)
+
1√
n
n∑
i=1
(ei(t; θ̂n)− ei(t; θ∗))gt(Xi, θ∗)
+
1√
n
n∑
i=1
ei(t; θ
∗)(gt(Xi, θ̂n)− gt(Xi, θ∗))
+
1√
n
n∑
i=1
(ei(t; θ̂n)− ei(t; θ∗))(gt(Xi, θ̂n)− gt(Xi, θ∗))
≡ 1√
n
n∑
i=1
ei(t; θ
∗)gt(Xi, θ
∗) + S1n,t + S2n,t + S3n,t.
We first show that S1n,t = −
√
n(θ̂n − θ∗)⊤∆t(θ∗) + op(1). To this end, note that
S1n,t =− 1√
n
n∑
i=1
(qt(Xi, θ̂n)− qt(Xi, θ∗))gt(Xi, θ∗)
=− 1
n
n∑
i=1
gt(Xi, θ
∗)
∂qt(Xi, θ˜n)
∂θ⊤
√
n(θ̂n − θ∗)
=− E[gt(X, θ∗)g⊤t (X, θ∗)]
√
n(θ̂n − θ∗) + op(1),
with θ˜n lying between θ̂n and θ
∗, where the second equality follows by the MVT, and the
last equality follows from the ULLN of Newey and McFadden (1994, Lemma 2.4), and
Assumptions 2–3.
It thus remains to show that both S2n,t and S3n,t are asymptotically negligible. First
note that
S2n,t =
√
n(θ̂n − θ∗)⊤ 1
n
n∑
i=1
ei(t; θ
∗)
∂gt(Xi, θ˜n)
∂θ
=
√
n(θ̂n − θ∗)⊤E
[
e(t; θ∗)
∂gt(X, θ
∗)
∂θ
]
+ op(1)
=op(1),
with θ˜n lying between θ̂n and θ
∗, where the first equality follows by MVT, the second
equality by ULLN of Newey and McFadden (1994, Lemma 2.4), and the last equality
by Assumptions 2–3 as well as the law of iterated expectations (LIE) under the null
hypothesis H0.
For the last term S3n,t, we have
√
nS3n,t =−
n∑
i=1
(qt(Xi, θ̂n)− qt(Xi, θ∗))(gt(Xi, θ̂n)− gt(Xi, θ∗))
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=−√n(θ̂n − θ∗)⊤ 1
n
n∑
i=1
∂qt(Xi, θ˜n)
∂θ
∂gt(Xi, θ˘n)
∂θ⊤
√
n(θ̂n − θ∗)
=−√n(θ̂n − θ∗)⊤E
[
gt(X, θ
∗)
∂gt(X, θ
∗)
∂θ⊤
]√
n(θ̂n − θ∗) + op(1)
=Op(1),
with θ˜n and θ˘n both lying between θ̂n and θ
∗, where the second equality follows by MVT,
the third equality by ULLN of Newey and McFadden (1994, Lemma 2.4), and the last
equality by Assumptions 2–3. Thus, S3n,t = Op(n
−1/2) = op(1). This ends the proof of
Lemma A.2. 
The next two lemmas establish the uniform convergence of Gn,t(β, u; θ̂n) and ∆
−1
n,t(θ̂n)
to Gt(β, u; θ
∗)and ∆−1t (θ
∗), respectively.
Lemma A.3 Suppose Assumptions 1–3 hold. Then, for each t ∈ T , we have that
sup
(β,u)∈Πpro
∣∣∣Gn,t(β, u; θ̂n)−Gt(β, u; θ∗)∣∣∣ = op(1).
Proof of Lemma A.3: The proof follows directly from the ULLN ofNewey and McFadden
(1994, Lemma 2.4). 
Lemma A.4 Suppose Assumptions 1–3 hold. Then, for each t ∈ T , we have that
∆−1n,t(θ̂n) = ∆
−1
t (θ
∗) + op(1).
Proof of Lemma A.4: The proof follows from the ULLN of Newey and McFadden
(1994, Lemma 2.4) and the continuous mapping theorem. 
With the help of Lemmas A.1–A.4, we are ready to proceed with the proofs of our
main theorems.
Proof of Theorem 1: We first establish the uniform asymptotic representation of
Rdpron,t (β, u; θ̂n), which states that R
dpro
n,t (β, u; θ̂n) is asymptotically invariant to θ̂n. Based
on the representation, we prove the weak convergence of Rdpron,t (β, u; θ̂n). Lastly, the
limiting null distribution of CvMdpron can be obtained by standard techniques.
By a straightforward decomposition, we have
Rdpron,t (β, u; θ̂n) =
1√
n
n∑
i=1
ei(t; θ̂n)
{
1
(
β⊤Xi ≤ u
)− g⊤t (Xi, θ̂n)∆−1n,t(θ̂n)Gn,t(β, u; θ̂n)}
=Rpron,t (β, u; θ̂n)−G⊤n,t(β, u; θ̂n)∆−1n,t(θ̂n)
1√
n
n∑
i=1
ei(t; θ̂n)gt(Xi, θ̂n)
≡Rpron,t (β, u; θ̂n)−G⊤n,t(β, u; θ̂n)∆−1n,t(θ̂n)Sn,t.
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Then, by Lemmas A.1–A.4, we have that
Rdpron,t (β, u; θ̂n)
=
1√
n
n∑
i=1
ei(t; θ
∗)1
(
β⊤Xi ≤ u
)−G⊤t (β, u; θ∗)√n(θ̂n − θ∗)
−G⊤t (β, u; θ∗)∆−1t (θ∗)
[
1√
n
n∑
i=1
ei(t; θ
∗)gt(Xi, θ
∗)−∆t(θ∗)
√
n(θ̂n − θ∗)
]
+ op(1)
=
1√
n
n∑
i=1
ei(t; θ
∗)
{
1
(
β⊤Xi ≤ u
)−G⊤t (β, u; θ∗)∆−1t (θ∗)gt(Xi, θ∗)}+ op(1)
≡ 1√
n
n∑
i=1
ei(t; θ
∗)Pt1
(
β⊤Xi ≤ u
)
+ op(1),
uniformly in (β, u) ∈ Πpro.
The weak convergence of
Rdpron0,t (β, u; θ
∗) ≡ 1√
n
n∑
i=1
ei(t; θ
∗)Pt1
(
β⊤Xi ≤ u
)
, (A.1)
and consequently the weak convergence of Rdpron,t (β, u; θ̂n) to the centered Gaussian pro-
cess Rdpro∞,t with covariance structure K
dpro
t ((β, u) , (β
′, u′)) specified in (14) can be readily
obtained by showing that the finite-dimensional distributions of Rdpron0,t (β, u; θ
∗) converge
to those of Rdpro∞,t and the stochastic equicontinuity of R
dpro
n0,t (β, u; θ
∗) by a straightfor-
ward application of Donsker property of the class of linear indicator functions F ={
x 7→ 1(β⊤x ≤ u) : (β, u) ∈ Πpro
}
.
For the convergence in distribution of test statistic CvMdpron , we will prove that∑
t∈T
an(t)
∫
Πpro
(
Rdpron,t (β, u; θ̂n)
)2
Fn,β(du) dβ
d−→
∑
t∈T
a(t)
∫
Πpro
(
Rdpro∞,t (β, u)
)2
Fβ(du) dβ.
Given the assumption that an(t)
p−→ a(t) for each t ∈ T , according to Slutsky’s theorem,
it suffices to show that, for each t ∈ T ,∫
Πpro
(
Rdpron,t (β, u; θ̂n)
)2
Fn,β(du) dβ
d−→
∫
Πpro
(
Rdpro∞,t (β, u)
)2
Fβ(du) dβ.
First of all, note that the weak convergence of the double-projected process Rdpron,t (β, u; θ̂n)
and the Skorohod construction [see, e.g., Serfling, 1980] yield
sup
(β,u)∈Πpro
∣∣∣Rdpron,t (β, u; θ̂n)− Rdpro∞,t (β, u)∣∣∣ a.s.−−→ 0. (A.2)
Note that the empirical distribution function Fn,β(u) ≡ n−1
∑n
i=1 1
(
β⊤Xi ≤ u
)
estimates
CDF Fβ(u) := P
(
β⊤X ≤ u) a.s. uniformly for (β, u) ∈ Πpro by invoking the ULLN
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of Jennrich (1969) or the generalization by Wolfowitz (1954) of the Glivenko–Cantelli
theorem. That is,
sup
(β,u)∈Πpro
|Fn,β(u)− Fβ(u)| a.s.−−→ 0. (A.3)
Now write∣∣∣∣∣
∫
Πpro
(
Rdpron,t (β, u; θ̂n)
)2
Fn,β(du) dβ −
∫
Πpro
(
Rdpro∞,t (β, u)
)2
Fβ(du) dβ
∣∣∣∣∣
≤
∣∣∣∣∣
∫
Πpro
[(
Rdpron,t (β, u; θ̂n)
)2
−
(
Rdpro∞,t (β, u)
)2]
Fn,β(du) dβ
∣∣∣∣∣
+
∣∣∣∣∣
∫
Πpro
(
Rdpro∞,t (β, u)
)2
[Fn,β(du)− Fβ(du)] dβ
∣∣∣∣∣ .
The first term of the right-hand side of the above inequality is o(1) a.s. due to (A.2). The
trajectories of the limiting process Rdpro∞,t (β, u) are bounded and continuous a.s.. Then, by
applying the Helly–Bray Theorem (see p. 97 in Rao, 1965) to each of these trajectories
and taking into account (A.3), we have that the second term of the right-hand side of
the above inequality is also o(1) a.s.. This concludes the proof of Theorem 1. 
Proof of Theorem 2: Under Assumptions 1–3, uniformly in (β, u) ∈ Πpro,
sup
(β,u)∈Πpro
∣∣∣∣∣ 1n
n∑
i=1
{
ei(t; θ̂n)Pn,t1
(
β⊤Xi ≤ u
)− E [e(t; θ∗)P1 (β⊤X ≤ u)]}∣∣∣∣∣
= sup
(β,u)∈Πpro
∣∣∣∣ 1√nRdpron,t (β, u; θ̂n)− E [(pt (X)− qt (X, θ∗))P1 (β⊤X ≤ u)]
∣∣∣∣
=op(1)
by ULLN of Newey and McFadden (1994, Lemma 2.4) and similar arguments in proving
Lemmas A.1, A.3 and A.4. 
Proof of Theorem 3: Note that under the local alternatives H1,n in (15), we have that
uniformly in (β, u) ∈ Πpro:
Rdpron,t (β, u; θ̂n) =
1√
n
n∑
i=1
(
ei(t; θ̂n)− rt(Xi)√
n
)
Pn,t1
(
β⊤Xi ≤ u
)
+
1
n
n∑
i=1
rt(Xi)Pn,t1
(
β⊤Xi ≤ u
)
=
1√
n
n∑
i=1
(
ei(t; θ
∗)− rt(Xi)√
n
)
Pt1
(
β⊤Xi ≤ u
)
+ E
[
rt(X)Pt1
(
β⊤X ≤ u)]+ op(1)
≡Rdpron1,t (β, u; θ∗) + δt(β, u) + op(1)
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⇒Rdpro∞,t + δt,
where the second equality follows by similar arguments in proving Theorem 1 and by
ULLN. Since ei(t; θ
∗) − n−1/2rt(Xi) forms a zero mean and i.i.d. summand in this local
alternative framework, we can apply the functional central limit theorem to Rdpron1,t (β, u; θ
∗)
by checking the finite-dimensional distributions ofRdpron1,t (β, u; θ
∗) and its stochastic equicon-
tinuity, just as we applied it to Rdpron0,t (β, u; θ
∗) defined in (A.1). This leads toRdpron1,t (β, u; θ
∗)⇒
Rdpro∞,t . The last step thus follows and we finish the proof of Theorem 3. 
Proof of Theorem 4: As in Theorem 1, we have the following decomposition:
Rdpro,∗n,t (β, u; θ̂n)
=
1√
n
n∑
i=1
ei(t; θ̂n)
(
1
(
β⊤Xi ≤ u
)− g⊤t (Xi, θ̂n)∆−1n,t(θ̂n)Gn,t(β, u; θ̂n))Vi
=
1√
n
n∑
i=1
ei(t; θ̂n)1
(
β⊤Xi ≤ u
)
Vi −G⊤n,t(β, u; θ̂n)∆−1n,t(θ̂n)
1√
n
n∑
i=1
ei(t; θ̂n)gt(Xi, θ̂n)Vi
≡ Rpro,∗n,t (β, u; θ̂n)−G⊤n,t(β, u; θ̂n)∆−1n,t(θ̂n)S∗n,t.
Conditional on the original sample, it follows from a stochastic equicontinuity (or
MVT) argument and the consistency of θ̂n to θ
∗ that, uniformly in (β, u) ∈ Πpro,
Rpro,∗n,t (β, u; θ̂n)
=
1√
n
n∑
i=1
ei(t; θ
∗)1
(
β⊤Xi ≤ u
)
Vi +
1√
n
n∑
i=1
(
ei(t; θ̂n)− ei(t; θ∗)
)
1
(
β⊤Xi ≤ u
)
Vi
=
1√
n
n∑
i=1
ei(t; θ
∗)1
(
β⊤Xi ≤ u
)
Vi + op(1),
and
S∗n,t =
1√
n
n∑
i=1
ei(t; θ
∗)gt(Xi, θ
∗)Vi
+
1√
n
n∑
i=1
ei(t; θ
∗)
(
gt(Xi, θ̂n)− gt(Xi, θ∗)
)
Vi
+
1√
n
n∑
i=1
(
ei(t; θ̂n)− ei(t; θ∗)
)
gt(Xi, θ
∗)Vi
+
1√
n
n∑
i=1
(
ei(t; θ̂n)− ei(t; θ∗)
)(
gt(Xi, θ̂n)− gt(Xi, θ∗)
)
Vi
=
1√
n
n∑
i=1
ei(t; θ
∗)gt(Xi, θ
∗)Vi + op(1).
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Thus, by Lemmas A.3 and A.4, uniformly in (β, u) ∈ Πpro,
Rdpro,∗n,t (β, u; θ̂n) =
1√
n
n∑
i=1
ei(t; θ
∗)(1
(
β⊤Xi ≤ u
)−G⊤t (β, u; θ∗)∆−1t (θ∗)gt(Xi, θ∗))Vi + op(1)
=
1√
n
n∑
i=1
ei(t; θ
∗)Pt1
(
β⊤Xi ≤ u
)
Vi + op(1)
≡ Rdpro,∗n0,t (β, u; θ∗) + op(1),
leading to the multiplier bootstrapped version of Rdpron0,t (β, u; θ
∗) defined in (A.1).
Recall the properties of the sequence of multipliers {Vi}ni=1. The rest of the proof
then follows readily from the multiplier central limit theorem applied to the (infeasible)
multiplier bootstrapped double-projected process Rdpro,∗n0,t (β, u; θ
∗) regardless whether the
null hypothesis holds or not (see van der Vaart and Wellner, 1996, Theorem 2.9.2, p.
179), and the continuous mapping theorem. 
Appendix B: Simulation exercise for ordered treat-
ments
In this section we consider ordered, multinomial treatments with J = 2. Specifically, we
consider three treatment groups, T = {0, 1, 2}, whose assignment mechanisms are given
by the following conditional distributions:
P (T ≤ t|X) = Λ
(
π√
3
αt − φ (X)
γ (X)
)
, t = 0, 1,
where Λ (·) is the logistic CDF, i.e., Λ (a) = exp (a) / (1 + exp (a)), α1 > α0, and of
course, P (T ≤ 2|X) = 1 a.s.1. We vary φ (X), γ (X) and αt as following:
DGP11. φ (X) = −
∑10
j=1Xj
8
, γ (X) = 1, α0 = −1, α1 = 0.5.
DGP12. φ (X) =
∑10
j=1Xj
10
−X1X2, γ (X) = 1, α0 = −1.2, α1 = 0;
DGP13. φ (X) =
−∑10j=1Xj
10
+
X1
∑5
k=2Xk
2
, γ (X) = 1, α0 = 0, α1 = 1.5;
DGP14. φ (X) = −
∑10
j=1Xj
6
+
∑10
k=1X
2
k
10
, γ (X) = 1, α0 = 0, α1 = 1.5;
1 The scaling constant pi/
√
3 is to make the generalized propensity score coefficients comparable to those
used in Section 5.1, where we adopt a Gaussian link function instead of a logistic link function as we
do here.
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DGP15. φ (X) = 0.1
5∑
j=1
Xj, γ (X) = exp
(
−0.2
10∑
k=1
Xj
)
, α0 = −0.5, α1 = 1.
For each of these five DGPs, X = (X1, X2, . . . , X10)
⊤ with {Xj}10j=1 defined as in §5.1.
For each of these DGPs we consider the following potential outcomes:
Y (0) = 1+X⊤β0+ u (0) , Y (1) = 2+X
⊤β1+ u (1) , and Y (2) = 3+X
⊤β2+ u (2) ,
where u (0), u (1) and u (2) are independent normal random variables with mean zero
and variance 1, β0 = (−4,−4,−4,−4,−4, 4, 4, 4, 4, 4)⊤, β1 = −β0, and β2 = 3. The
observed outcome is Y = 1 {D = 0}Y (0) + 1 {D = 1}Y (1) + 1 {D = 2}Y (2), and the
true ATE1,0 = 1, ATE2,0 = 2, and ATE2,1 = 1.
For DGP6−DGP10, the H0 considered is
H0 : ∃θ∗ =
(
α0, α1, δ
⊤
0
)⊤ ∈ Θ : P (T ≤ t|X) = Λ (αt −X⊤δ0) a.s. for t = 0, 1. (B.1)
We estimate θ∗ using the ordered logit (proportional odds) likelihood, i.e.,
θ̂n = arg max
(α0,α1,δ⊤)
⊤
∈Θ
n∑
i=1
2∑
t=0
[
1 {Ti = t} ln
(
Λ
(
αt −X⊤i δ
)− Λ (αt−1 −X⊤i δ))] ,
where, with some abuse of notation, α−1 ≡ −∞ and α2 ≡ +∞. Clearly, DGP11 falls
under H0, whereas DGP12 − DGP15 fall under H1, i.e., the negation of (B.1). Note
that DGPs in the ordered treatment setup resemble those in the binary setup described
in Section 5.1.
In the ordered setup, our proposed test statistic CvMdpron is given by (12) with
ei
(
t; θ̂n
)
= 1 (Ti ≤ t)−Λ
(
αn,t −X⊤i δn
)
, and the score function defined accordingly. That
is, we use (12) with weight an(t) ≡ 1 for every t and n. Although Sant’Anna and Song
(2019) only considered specification tests for binary treatments, we note that their tests
can be extended to test (B.1) by using the following test statistic:
CvMss,on = CvM
ss,o
n,0 + CvM
ss,o
n,1 , (B.2)
such that, for t = 0, 1,
CvMss,on,t =
1
n
n∑
i=1
(
Rss,on,t
(
qt
(
Xi, θ̂n
)))2
,
qt
(
Xi, θ̂n
)
= Λ
(
αn,t −X⊤i δn
)
, ej(t; θ̂n) = 1 (Tj ≤ t)− qt
(
Xj , θ̂n
)
,
Rss,on,t (u) ≡
1√
n
n∑
j=1
ej(t; θ̂n)Pn,t1
(
qt
(
Xj , θ̂n
)
≤ u
)
,
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with projection-based weights given by
Pn,t1 (qt (X, θ) ≤ u) = 1 (qt (X, θ) ≤ u)− g⊤t (X, θ)∆−1n,t (θ)Gn,t (u, θ) , (B.3)
and gt(x, θ), Gn,t(u, θ) and ∆n,t (θ) defined analogously to the binary treatment setup. It
is important to emphasize that (B.2) is a test statistic for an implication of (B.1), i.e.,
(B.2) is a test statistic for the following null hypothesis:
H ′0 : ∃θ∗ =
(
α0, α1, δ
⊤
0
)⊤
∈ Θ : E [e(t; θ∗)|Λ (αt −X⊤δ0)] = 0 a.s. for t = 0, 1,
where e(t; θ∗) = 1(T ≤ t) − Λ (αt −X⊤δ0). Thus, although CvMss,on,t also avoids the
“curse of dimensionality”, we cannot ensure its consistency against general nonparametric
alternatives H1, only against H
′
1, the negation of H
′
0
2. The statistic CvMdpron,t thus is
always preferred to.
The simulation results are presented in Table B.1. As it is evident from Table B.1,
our proposed double-projected test, CvMdp,ordn , and the extension of Sant’Anna and Song
(2019)’s test, CvMss,on , have finite sample size close to their nominal size. Furthermore,
when the generalized propensity score is correctly specified, all IPW estimators for the
average treatment effects have little to no bias, their RMSE reduces with sample size,
and their coverage probability is very close to its nominal level.
Under model misspecifications as in DGP12−DGP15, the IPW estimators (22) are
biased for the true average treatment effects and, in general, such biases do not reduce
with sample size. In addition, inference procedures for the treatment effects can be
unreliable. Thus, detecting generalized propensity score misspecifications can prevent
misleading inference about the causal effect of interest. As in the binary setup, our
proposed test CvMdpron performs remarkably well and strictly dominate CvM
ss,o
n in all
considered DGPs. For instance, for DGP12 with n = 200, CvMdpron is eight times more
powerful than CvMss,on ; for DGP13 with n = 200, CvM
dpro
n rejects (B.1) more than four
times more often than CvMss,on . As mentioned before, part of this gain of power can be
credited to the fact that CvMss,on may have trivial power against some directions and this
can have important practical consequences. On the other hand, CvMdpron is consistent
against all nonparametric (fixed) alternatives, highlighting its potential attractiveness.
2 Given the ordered nature of the treatment assignment, we know that the sigma algebra generated
by
(
Λ
(
α0 −X⊤δ0
)
,Λ
(
α1 −X⊤δ0
))
is equivalent to the sigma algebra generated by Λ
(
αt −X⊤δ0
)
,
t = 0, 1, implying that we can rewrite H ′
0
as
H ′
0
: ∃θ0 = (α0, α1, δ
⊤
0
)⊤ ∈ Θ : E [e(t; θ0)|Λ (αt −X⊤δ0) ,Λ (α1 −X⊤δ0)] = 0 a.s. for t = 0, 1.
Thus, in the ordered treatment setup, augmenting the conditioning set to
Λ
(
α0 −X⊤δ0
)
,Λ
(
α1 −X⊤δ0
)
does not affect the power properties of CvM ss,on .
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Table B.1: Monte Carlo results under designs DGP6-DGP10: Ordered Treatment
DGP n CvMdpron CvM
ss,o
n Bias1,0 Bias2,0 RMSE1,0 RMSE2,0 COV1,0 COV2,0
11 200 0.057 0.054 -0.090 -0.100 2.362 2.313 0.958 0.957
11 400 0.045 0.047 -0.038 -0.045 1.682 1.586 0.949 0.949
11 800 0.040 0.061 -0.025 -0.051 1.172 1.052 0.949 0.957
12 200 0.968 0.121 0.951 0.821 2.508 1.695 0.938 0.930
12 400 1.000 0.150 0.794 0.782 1.803 1.280 0.931 0.886
12 800 1.000 0.248 0.855 0.796 1.417 1.046 0.891 0.805
13 200 0.926 0.211 1.232 1.604 2.376 2.289 0.904 0.897
13 400 1.000 0.450 1.297 1.605 1.943 1.929 0.852 0.739
13 800 1.000 0.713 1.277 1.637 1.629 1.798 0.756 0.425
14 200 0.443 0.176 0.663 0.768 2.578 2.530 0.944 0.949
14 400 0.907 0.395 0.596 0.808 1.744 1.817 0.946 0.918
14 800 1.000 0.693 0.622 0.877 1.313 1.403 0.925 0.887
15 200 0.065 0.072 -0.162 -4.100 2.203 4.570 0.952 0.505
15 400 0.179 0.139 -0.113 -4.086 1.471 4.279 0.952 0.132
15 800 0.488 0.331 -0.146 -4.089 1.013 4.183 0.964 0.005
Note: Simulations based on 1,000 Monte Carlo experiments. “CvMdpron ” stands for our proposed Crame´r-
von Mises tests (12). “CvM ss,on ” stands for the extension of Sant’Anna and Song (2019)’s test defined
in (B.2). Finally, “Biask,s”, “RMSEk,s” and “COVk,s” stand for the average simulated bias, average
simulated root mean squared error, and 95% coverage probability for the ATEk,s estimator ATEn,k,s as
defined in (22). The 95% coverage probability is based on the percentile bootstrap with 499 draws. See
the main text for further details.
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